Figure 3.
Forest plot of the effect of MRD on relapse, RFS, and OS in the whole cohort for various subgroups. Relapse (A), RFS (B), and OS (C). MRDhigh: patients with WT1/100ABL >2.5% in BM or >0.5% in PB. MRDlow, patients with WT1/100ABL <2.5% in BM or <0.5% in PB. HR, hazard ratio. WBC count, 109/L. Pval: P-value; Yo, years old; Fav, favorable; Int, intermediate; Unfav, unfavorable. For NPM1 and FLT3-ITD mutations: 0, not mutated, and 1, mutated.